These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3878975)

  • 21. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome.
    Kurlan R; Como PG; Deeley C; McDermott M; McDermott MP
    Clin Neuropharmacol; 1993 Apr; 16(2):167-72. PubMed ID: 8477412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Open trial of fluoxetine in obsessive-compulsive disorder.
    Jenike MA; Buttolph L; Baer L; Ricciardi J; Holland A
    Am J Psychiatry; 1989 Jul; 146(7):909-11. PubMed ID: 2787123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome.
    Riddle MA; Leckman JF; Hardin MT; Anderson GM; Cohen DJ
    Am J Psychiatry; 1988 Sep; 145(9):1173-4. PubMed ID: 3046386
    [No Abstract]   [Full Text] [Related]  

  • 24. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder.
    Tollefson GD; Rampey AH; Potvin JH; Jenike MA; Rush AJ; kominguez RA; Koran LM; Shear MK; Goodman W; Genduso LA
    Arch Gen Psychiatry; 1994 Jul; 51(7):559-67. PubMed ID: 8031229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine for depression.
    Med Lett Drugs Ther; 1988 Apr; 30(764):45-7. PubMed ID: 3258399
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment.
    Monteleone P; Catapano F; Tortorella A; Di Martino S; Maj M
    Psychoneuroendocrinology; 1995; 20(7):763-70. PubMed ID: 8848522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group.
    Montgomery SA; McIntyre A; Osterheider M; Sarteschi P; Zitterl W; Zohar J; Birkett M; Wood AJ
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):143-52. PubMed ID: 8364350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome.
    Como PG; Kurlan R
    Neurology; 1991 Jun; 41(6):872-4. PubMed ID: 2046933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder.
    Markovitz PJ; Stagno SJ; Calabrese JR
    Am J Psychiatry; 1990 Jun; 147(6):798-800. PubMed ID: 2188516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder.
    Neziroglu F; Yaryura-Tobias JA; Walz J; McKay D
    J Child Adolesc Psychopharmacol; 2000; 10(4):295-306. PubMed ID: 11191690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report].
    Wandzel L
    Psychiatr Pol; 1997; 31(4):429-35. PubMed ID: 9527686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.
    McDougle CJ; Barr LC; Goodman WK; Pelton GH; Aronson SC; Anand A; Price LH
    Am J Psychiatry; 1995 Dec; 152(12):1812-4. PubMed ID: 8526253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obsessive-compulsive disorder presenting with gender incongruence obsessions.
    Uvais NA; Sreeraj VS
    Asian J Psychiatr; 2017 Dec; 30():77-78. PubMed ID: 28837942
    [No Abstract]   [Full Text] [Related]  

  • 35. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder.
    Blázquez A; Mas S; Plana MT; Gassó P; Méndez I; Torra M; Arnaiz JA; Lafuente A; Lázaro L
    J Clin Psychopharmacol; 2014 Jun; 34(3):318-26. PubMed ID: 24743718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obsessive compulsive disorder and depression--first results of a prospective study on 74 patients.
    Demal U; Zitterl W; Lenz G; Zapotoczky HG; Zitterl-Eglseer K
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):801-13. PubMed ID: 8870065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP; Sobhan MA
    Pak J Pharm Sci; 2013 Jan; 26(1):95-8. PubMed ID: 23261733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of fluoxetine by aminoglutethimide, an adrenal steroid suppressant, in obsessive-compulsive disorder resistant to SSRIs: a case report.
    Chouinard G; Bélanger MC; Beauclair L; Sultan S; Murphy BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Aug; 20(6):1067-79. PubMed ID: 8888111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind trial of fluoxetine in pathologic skin picking.
    Simeon D; Stein DJ; Gross S; Islam N; Schmeidler J; Hollander E
    J Clin Psychiatry; 1997 Aug; 58(8):341-7. PubMed ID: 9515971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.